Cancer of Head and Neck
Oncology
1
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
1100%
+ 1 programs with unclassified modality
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
AstellasErlotinib
GenomicsOncoPrism™ assay
Clinical Trials (2)
Total enrollment: 1,675 patients across 2 trials
Phase I Chemoprevention Trial With Green Tea Polyphenon E & Erlotinib in Patients With Premalignant Lesions of the Head & Neck
Start: Mar 2010Est. completion: May 201825 patients
Phase 1Completed
A Multicenter Cancer Biospecimen Collection Study
Start: Feb 2020Est. completion: Feb 20271,650 patients
N/ARecruiting
Related Jobs in Oncology
Cell Therapy Account Manager（北陸）
Gilead Sciences
Japan - Tokyo
Just now
Leo Cancer Care: Senior In-House Counsel/General Counsel
Leo Cancer Care
Middleton, Wisconsin
6h ago
Summer Intern - Computational Chemistry & Artificial Intelligence
Arvinas
Remote
8h ago
Executive Medical Director, Oncology Early Development
AbbVie
Florham Park, NJ
8h ago
Executive Medical Director, Oncology Early Development
AbbVie
South San Francisco, CA
8h ago
Executive Medical Director, Oncology Early Development
AbbVie
North Chicago, IL
8h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 1,675 patients
2 companies competing in this space